SPARTES acquired by ANDERA PARTNERS

PROMAN has announced the acquisition of the HR tech scale-up Embarq. This transaction strategically propels the acquirer into a top-tier position within the "Portage Salarial" sector, effectively combining the target's high-growth digital platform with the industrial scale of a European HR giant. The strategic rationale for the deal is rooted in the booming demand for professional autonomy and corporate flexibility, a market currently growing at 20% annually. By integrating Embarq’s proprietary "phygital" ecosystem and its high-profile pool of 4,000 interim managers and IT experts, PROMAN increases its sector-specific revenue to nearly €200 million, representing a 9% total market share. The partnership is designed to leverage the target's scalable technology to absorb rapid growth both domestically and internationally, while maintaining the transparency and proximity values that defined the start-up’s success. For the founders, joining PROMAN provides the financial and operational resources required to challenge traditional industry codes on a global scale. This merger highlights the ongoing institutionalization of the freelance economy, where established staffing leaders are increasingly acquiring digital-native platforms to secure specialized talent pools and modernize their service delivery models.

ADIT finalized its 5th LBO with the entry of 8 new investors (UI, Covea, MACSF, etc.) taking 50% of the capital for EUR270M. Historical shareholders (Sagard, Parquest, Amundi) and Management (7%) retain the remaining 50%. Bpifrance reinforces its position (15%) alongside the French State (via APE in DCI). The transaction is supported by a EUR375M unitranche debt (Tikehau, Five Arrows, Eurazeo, CIC, Natixis) to fund a plan aimed at doubling the company's size by 2030.

Groupe EIF reorganizes its shareholding through its third LBO ("LBO Ter"). Five new investment funds join the capital to support the group's domestic and international development. The management team strengthens its majority position while opening the capital to all employees. This partnership aims to accelerate the deployment of SaaS solutions for tax performance and to lead a buy-and-build strategy across Europe, particularly in Italy and Benelux, following the acquisition of Forecast Consulting in Belgium.

Bridgepoint acquired a significant minority stake in Argon & Co, joining the existing management team and partners who retain majority ownership. The incumbent financial sponsor, Ardian (which first invested in 2020), also reinvested a minority stake in the business. The transaction aims to fund the next phase of Argon & Co's expansion, specifically targeting growth in North America and Europe. Bridgepoint will support an enhanced M&A strategy to consolidate the operations consulting market.

Siparex Entrepreneurs and Bpifrance acquired a majority stake in NOOUS, marking the group's first opening of capital since its creation 25 years ago. The transaction orchestrates a managerial transition: historical founder retains a significant minority stake but passes the CEO role, while 8 key managers (7 of whom are women) invest in the company. The new funds and governance structure aim to accelerate NOOUS's development through organic expansion of its service offer and targeted external growth acquisitions to consolidate the fragmented HR consulting market.

Ayming has announced a strategic capital reorganization. Andera Partners, through its Andera MidCap 5 fund, has acquired a majority stake in the group. This transition marks a new growth cycle supported by the existing management team who are reinvesting significantly in the project. EMZ, a partner since 2022, is also renewing its commitment by maintaining a minority shareholding.

Blackstone acquired a majority stake in Citrin Cooperman from New Mountain Capital in a landmark deal valuing the firm at an enterprise value of over $2 billion. The strategic rationale focuses on continuing the firm's rapid consolidation of the fragmented regional accounting market and accelerating investments in AI and offshore delivery centers to improve margins. Partners of the firm reinvested a substantial portion of their equity, while the deal structure ensures the audit side remains independently owned to satisfy SEC and PCAOB independence standards.

CapMan has completed the divestment of its majority stake (92.7%) in CaPS to Proxer Bidco Oy. This transaction represents a strategic carve-out, allowing the seller to refocus its resources and capital on its core private asset fund management business. Originally an internal service unit, the target had evolved into a largely standalone business with limited operational links to the rest of the group, making the divestment a natural progression for its next growth phase. The sale significantly enhances the seller’s financial position, providing strong liquidity and a positive impact on 2024 earnings. Following the closing, the target will operate under a new ownership structure designed to facilitate further expansion across the Nordics and beyond, while continuing to serve its extensive network of members and vendors.

Telemos Capital has finalized a new investment partnership with Helios Global Group, marking the exit of the previous financial sponsor, NorthEdge. The strategic rationale for this transaction centers on a "global-platform" play, merging the target's technical operational depth in medical communications with the new sponsor's flexible capital and international expansion expertise. This transition effectively prepares the organization for its next stage of evolution, moving beyond its regional success to become a dominant global provider of integrated biopharma services. This operation allows the management team to execute a definitive structural expansion into new service lines and geographic territories, particularly in the North American market. By incorporating the group into a family-backed investment framework, the organization gains the stability required to harness innovative technologies and scale its internal infrastructure in alignment with its expanding client base. The maneuver optimizes the group's financial profile, facilitating further strategic add-on acquisitions following the successful integration of previous market access specialists. Ultimately, the partnership solidifies the group’s standing as a primary enabler of scientific narrative and health economic innovation, bridging the gap between clinical research and global market commercialization.

This transaction represents the enterprise's fifth consecutive Leveraged Buyout (LBO), marking a significant yet familiar restructuring of its cap table. The incoming lead financial sponsor steps in to successfully provide an exit for several incumbent minority investment funds. A defining characteristic of this operation is the massive, broad-based reinvestment from the executive leadership and a vast cohort of key employees, ensuring profound strategic alignment. The overall capitalization is robustly structured, featuring a comprehensive senior debt package syndicated across multiple tranches by an expanded consortium of historical banking partners. Crucially, this financing architecture includes substantial, dedicated acquisition credit lines strictly earmarked to rapidly trigger an aggressive, inorganic external growth campaign immediately following the successful completion of the customary regulatory closing conditions.